LCAT and liver cancer: The results demonstrated that LCAT and DNASE1L3 were significantly downregulated in liver cancer cells, while NEIL3, GAGE4, SLC1A5, MMP1, SCIN and GAGE1 mRNA expression levels were notably elevated (Fig. 7A), in agreement with the bioinformatics prognostic model described above.